View all news

    Late-breaking results show nipocalimab significantly improves Sjögren’s disease activity in a Phase 2 study

    06/15/2024
    Download(opens in new window)PDF

    Multimedia Files:

    View all news
    Questions? Please contact us:
    1-800-950-5089 investor-relations@its.jnj.com